An Open-Label, Single-Dose, Randomized, 2-Period, Crossover, Bioequivalence Study Between Two 5-mg Tablets and a New 10-mg Tablet Formulation of Lecozotan SR in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 18 Jan 2010
At a glance
- Drugs Lecozotan (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Wyeth
- 17 Aug 2007 Status changed from recruiting to completed.
- 12 Jul 2007 New trial record.